Biobot Analytics, Inc. — Form D/A
Biobot Analytics, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2021-11-17. The offering totals $20.8M, of which $20.8M was reported sold. Industry: Other.
Offering
- Filed: 2021-11-17
- Form: D/A
- Accession: 0001567619-21-020625
- Industry: Other
- Exemptions: 06b
- Total offering: $20.8M
- Amount sold: $20.8M
- Investors: 26
- Date of first sale: 2021-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-409119
Issuer
- Name: Biobot Analytics, Inc.
- CIK: 0001809780
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 501 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02139
- Phone: 617-249-3586
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Ann Guadalupe DeWitt | Director | Cambridge, MA |
| Rich-Henry Guadalupe Schabowsky | Director | Cambridge, MA |
| Vivek Guadalupe Pattipati | Director | Cambridge, MA |
| Newsha Guadalupe Ghaeli | Director | Cambridge, MA |
| Newsha Guadalupe Ghaeli | Executive Officer | Cambridge, MA |
| Andrew Guadalupe Perlman | Director | Cambridge, MA |
| Mariana Guadalupe Matus Garcia | Director | Cambridge, MA |
| Mariana Guadalupe Matus Garcia | Executive Officer | Cambridge, MA |
Other filings by this issuer (3)
More